Form 13D/A CYCLERION THERAPEUTICS For: 21 July
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cyclerion Therapeutics Inc (CYCN)
Cyclerion Therapeutics Inc stock price live, this page displays NASDAQ CYCN stock exchange data. View the CYCN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Cyclerion Therapeutics Inc real time stock price chart below.
What Is the Cyclerion Therapeutics Inc Stock Price Today?
The Cyclerion Therapeutics Inc stock price today is 3.650.
What Is the Stock Symbol for Cyclerion Therapeutics Inc?
The stock symbol for Cyclerion Therapeutics Inc is "CYCN."
What Stock Exchange Does Cyclerion Therapeutics Inc Trade On?
Cyclerion Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Cyclerion Therapeutics Inc a Good Stock to Buy?
Determining whether Cyclerion Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CYCN quote. (ISIN: US23255M2044)
What Is the Cyclerion Therapeutics Inc Stock Price Today?
The Cyclerion Therapeutics Inc stock price today is 3.650.
What Is the Stock Symbol for Cyclerion Therapeutics Inc?
The stock symbol for Cyclerion Therapeutics Inc is "CYCN."
What Stock Exchange Does Cyclerion Therapeutics Inc Trade On?
Cyclerion Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Cyclerion Therapeutics Inc a Good Stock to Buy?
Determining whether Cyclerion Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CYCN quote. (ISIN: US23255M2044)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.560
3.760
52 wk Range
1.027
8.480
CYCN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.5603.760
52 wk Range
1.0278.480
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CYCN Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Form 13G CYCLERION THERAPEUTICS INC For: 7 May
- Investing.com
- Form 8K Cyclerion Therapeutics Inc For: 6 January
- Investing.com
- Cyclerion to merge with Korsana in $380 million deal
- Investing.com
- Form 13D/A CYCLERION THERAPEUTICS For: 21 July
- Investing.com
- Form 13G CYCLERION THERAPEUTICS INC For: 7 May
- Investing.com
- Cyclerion to merge with Korsana in $380 million deal
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy
Earnings
Latest Release
May 12, 2026
EPS / Forecast
-0.76 / --
Revenue / Forecast
-- / --
Compare CYCN to Peers and Sector
Metrics to compare | CYCN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCYCNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.9x | 5.5x | −0.4x | |
PEG Ratio | 0.11 | −0.34 | 0.00 | |
Price/Book | 2.3x | 3.8x | 2.6x | |
Price / LTM Sales | 7.8x | 4.0x | 3.0x | |
Upside (Analyst Target) | 119.2% | 94.3% | 54.6% | |
Fair Value Upside | Unlock | 19.9% | 9.7% | Unlock |
Cyclerion Therapeutics, Inc., a biopharmaceutical company, engages in the development of treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery. The company is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to treat cardiovascular diseases; and Praliciguat, a systemic sGC stimulator for the treatment of rare kidney disease. It has a license agreement with Akebia to develop, manufacture, medical affair, and commercializes Praliciguat and other related products. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Cyclerion Therapeutics (CYCN) Stock Price Today?
The Cyclerion Therapeutics stock price today is 3.650 USD.
What Stock Exchange Does Cyclerion Therapeutics Trade On?
Cyclerion Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Cyclerion Therapeutics?
The stock symbol for Cyclerion Therapeutics is "CYCN."
What Is the Cyclerion Therapeutics Market Cap?
As of today, Cyclerion Therapeutics market cap is 15.480M USD.
What Is Cyclerion Therapeutics's Earnings Per Share (TTM)?
The Cyclerion Therapeutics EPS (TTM) is -1.468.
From a Technical Analysis Perspective, Is CYCN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Cyclerion Therapeutics Stock Split?
Cyclerion Therapeutics has split 1 times.
How Many Employees Does Cyclerion Therapeutics Have?
Cyclerion Therapeutics has 1 employees.
What is the current trading status of Cyclerion Therapeutics (CYCN)?
As of Jul 21, 2026, Cyclerion Therapeutics (CYCN) is trading at a price of 3.650 USD, with a previous close of 3.650 USD. The stock has fluctuated within a day range of 3.560 USD to 3.760 USD, while its 52-week range spans from 1.027 USD to 8.480 USD.
What Is Cyclerion Therapeutics (CYCN) Price Target According to Analysts?
The average 12-month price target for Cyclerion Therapeutics is 8.000 USD, with a high estimate of 8 USD and a low estimate of 8 USD. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +119.18% Upside potential.
What Is the CYCN Premarket Price?
CYCN's last pre-market stock price is 3.530 USD. The pre-market share volume is 50.000, and the stock has decreased by -0.120, or -3.290%.
What Is the CYCN After Hours Price?
CYCN's last after hours stock price is 3.537 USD, the stock has decreased by -0.113, or -3.100%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.